safeT21express provides non-invasive analysis of fetal DNA by drawing blood from the mother. Their analysis can screen for various chromosomal diseases of the fetus, for example, Down Syndrome, Patau Syndrome, Edwards Syndrome and Sex Chromosome Aneuploidies. Currently, Xcelom is exclusively licensed to provide the safeT21express test.
|Company Name||Xcelom Limited|
|Year of Establishment||2014|
|No. of Employees||1-10|
|Fundraising History||1M USD (the Future Science Prize 2016)|
|Media Exposure||Ming Pao|
|Company Email||[email protected]|